MK2-IN-3
MK2-IN-3 is a potent and selective inhibitor of MAPKAP-K2 (MK-2), with an IC50 of 8.5 nM. MK2-IN-3 shows selectivity for MK-2 over MK-3, MK-5, ERK2, MNK1, p38a (IC50s=0.21, 0.081, 3.44, 5.7, and >100 μM, respectively) and MSK1, MSK2, CDK2, JNK2, IKK2 (IC50s>200 μM) . MK2-IN-3 can reduce TNFα production in both U937 cells and in vivo[1].
Product Specifications
CAS Number
724711-21-1
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
MAPKAPK2 (MK2)
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/mk2-in-3.html
Concentration
10mM
Purity
99.70
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
O=C1C2=C(NC(C3=CC(C4=CC5=CC=CC=C5N=C4)=NC=C3)=C2)CCN1
Molecular Formula
C21H16N4O
Molecular Weight
340.39
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD284 / TLR4 (TLR4/230), CF647 conjugate, 0.1mg/mL
CD21 (Mature B-Cell & Follicular Dendritic Cell Marker) (CR2/2754), CF568 conjugate, 0.1mg/mL
